CABOZANTINIB
UNII 1C39JW444G

Substance Identification & Data

This profile provides standardized clinical and technical data for Cabozantinib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 1C39JW444G.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 849217-68-1 and the RxNorm Concept ID (RxCUI) 1363268. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

1C39JW444G

CAS Registry Number

849217-68-1

RxNorm Concept ID

1363268

Detailed Substance Profile

Preferred Name

CABOZANTINIB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

1C39JW444G

The specific atomic composition represented as a molecular structure string.

InChIKey

C28H24FN3O5

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

ONIQOQHATWINJY-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C52200

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

25102847

Unique identification number in the NCBI database of chemical substances.

INN ID

9297

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

WW-154

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1(CC1)(C(=O)Nc2ccc(cc2)Oc3ccnc4cc(c(cc34)OC)OC)C(=O)Nc5ccc(cc5)F

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cabozantinib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.